MAP3K14 and metabolic syndrome: This suggests that among both genders, the LHR as an inexpensive and easy‐to‐access marker has a better diagnostic performance and could be promising alternatives to the traditional and expensive inflammatory markers such as hs‐CRP for the evaluation of inflammation in subjects with MetS.